---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-024839"
form_type: "8-K"
ticker: "LGVN"
cik: "0001721484"
company_name: "Longeveron Inc."
filed_at: "2026-03-09T23:59:59+00:00"
generated_at: "2026-05-15T17:59:50.163918+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Longeveron director Richard Kender resigns; audit committee loses financial expert

## Summary
- Richard Kender resigned from Board and Audit Committee effective March 3, 2026, due to becoming Executive Chairman and Interim CEO of Seres Therapeutics.
- Board appointed Dr. Roger Hajjar to Audit Committee on March 4, but no member currently qualifies as audit committee financial expert.
- Company plans to appoint or submit for election a qualified director by next annual meeting or within 180-day cure period.
- Kender's resignation not due to any disagreement with the Company's operations, policies, or management.

## SEC filing metadata
- accession: 0001213900-26-024839
- form_type: 8-K
- ticker: LGVN
- cik: 0001721484
- company_name: Longeveron Inc.
- filed_at: 2026-03-09T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.01, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1721484/000121390026024839/0001213900-26-024839-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1721484/000121390026024839/ea0280382-8k_longeveron.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-024839
- JSON: https://secwatch.observer/filing/0001213900-26-024839.json
- Plain text: https://secwatch.observer/filing/0001213900-26-024839.txt

## Source-grounded claims
- claim_id: abc5ed7e5da1f268ba64728cf888b34735431a03
  claim: Longeveron Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(2), 5605(c)(4)).
  evidence_excerpt: March 4, 2026 Longeveron Inc. (the “Company”) notified Nasdaq that, as a result of the resignation of Mr. Richard Kender as a member of the Board of Directors (the “Board”) of the Company and as chairman of the Audit Committee and the audit committee financial expert, as described below, the Company temporarily was no longer in compliance with Nasdaq Listing Rule 5605(c)(2)(A), which requires that the audit committee of a listed company be composed of at least three independent directors and that at least one member qualifies as an audit committee financial expert. On March 4, 2026, the Compan
  evidence_url: https://www.sec.gov/Archives/edgar/data/1721484/000121390026024839/0001213900-26-024839-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.